Cargando…

Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients

Detalles Bibliográficos
Autores principales:	Fakhri, Hajar, Ricken, Roland, Adli, Mazda, Fajol, Abul, Walter, Marc, Föller, Michael, Lang, Florian, Lang, Undine E., Lange, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Williams And Wilkins 2014
Materias:	Letters to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676336/ https://www.ncbi.nlm.nih.gov/pubmed/24949702 http://dx.doi.org/10.1097/JCP.0000000000000163

Ejemplares similares

Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants
por: Ricken, Roland, et al.
Publicado: (2017)

A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation
por: Glosse, Philipp, et al.
Publicado: (2018)

A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression
por: Bopp, Sandra K, et al.
Publicado: (2021)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The regulation of FGF23 under physiological and pathophysiological conditions
por: Rausch, Steffen, et al.
Publicado: (2022)

Fetuin-A, fibroblast growth factor 23 and inflammation in critically ill patients with sepsis
por: Fajol, Abul
Publicado: (2021)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Lactic acid induces fibroblast growth factor 23 (FGF23) production in UMR106 osteoblast-like cells
por: Alber, Jana, et al.
Publicado: (2021)

Myostatin regulates the production of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast–like cells
por: Ewendt, Franz, et al.
Publicado: (2021)

Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells
por: Münz, Sina, et al.
Publicado: (2023)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Case Report: Unexplained Mild Hypophosphatemia and Very High Serum FGF23 Concentrations
por: Bosman, Ariadne, et al.
Publicado: (2023)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats
por: Fajol, Abul, et al.
Publicado: (2021)

The production of fibroblast growth factor 23 is controlled by TGF-β2
por: Feger, Martina, et al.
Publicado: (2017)

Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC)
por: Pathare, Ganesh, et al.
Publicado: (2018)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

High Intake of Sodium Chloride for 28 Days Causes No Effect on Serum FGF23 Concentrations in Cats
por: Steffen, Carla, et al.
Publicado: (2022)

Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
por: Almilaji, Ahmad, et al.
Publicado: (2013)

Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)(2)D and normal FGF7 concentrations characterize patients with CKD
por: Kritmetapak, Kittrawee, et al.
Publicado: (2021)

Ion Transport in Eryptosis, the Suicidal Death of Erythrocytes
por: Föller, Michael, et al.
Publicado: (2020)

Increase of the Serum FGF-23 in Ossification of the Posterior Longitudinal Ligament
por: Kawaguchi, Yoshiharu, et al.
Publicado: (2018)

Diagnosis of TIO: Is Serum FGF23 Measurement always the Answer?
por: Ramakrishnan, Anantharaman, et al.
Publicado: (2020)

Additional evidence for the role of parathyroid hormone in adipose tissue browning
por: Fajol, Abul, et al.
Publicado: (2019)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids
por: Pukajło-Marczyk, Agnieszka, et al.
Publicado: (2019)

Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
por: Sitara, Despina, et al.
Publicado: (2008)

Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2
por: Lang, Elisabeth, et al.
Publicado: (2015)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l0pgp2v8g33huifjq6ejlcmbtd